Abstract
Introduction/BackgroundNeoadjuvant chemotherapy (NACT) has been advocated for patients with advanced stage epithelial ovarian carcinoma (EOC) with an aim to improve resectibility rate and survival. In this study we reported our...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have